June 27th, 2023

Shares of Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) soared over 100% in pre-market trading following the release of initial clinical data for BDTX-1535. The investigational drug, a fourth-generation epidermal growth factor receptor (EGFR) Maste. Read more

June 27th, 2023

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) posted third-quarter fiscal 2023 adjusted earnings per share (EPS) of $1.00, falling short of the consensus estimate of $1.07. For the full fiscal year 2023, the company revised its adjusted EPS guidanc. Read more

June 27th, 2023

Shares of American Equity Investment Life Holding Company (NYSE: AEL) experienced a significant surge in premarket trading, rising over 10%. The boost came after the company confirmed receiving a takeover proposal from Brookfield Reinsurance Ltd. (NY. Read more

June 27th, 2023

Applied Digital Corporation (Nasdaq: APLD) has revealed in a regulatory filing with the SEC a revenue guidance that falls below analysts' estimates. For the fiscal fourth quarter of 2023, the company expects that its overall revenues will be appro. Read more

June 26th, 2023

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS), a biopharmaceutical company specializing in ophthalmic therapeutics, has been maintained at a Buy rating by HC Wainwright & Co., who raised the price target from $40 to $44.  $TARS closed at $17.15. Read more

June 26th, 2023

Shares of Biomea Fusion, Inc. (Nasdaq: BMEA) surged to $32.87 during early trading on Monday, driven by positive clinical data from its Phase II study on BMF-219 in type 2 diabetes patients. However, by the end of the trading session, $BMEA closed at. Read more

June 26th, 2023

The Biden-Harris Administration has made a historic announcement, allocating over $40 billion to connect every American to affordable, reliable, high-speed internet. This marks the largest internet funding announcement in history and is part of the A. Read more

June 26th, 2023

MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company, announced positive results from its Phase 2 MIRA trial, evaluating the effectiveness and safety of the Nanobody sonelokimab, administered subcutaneously, in. Read more

June 26th, 2023

Alaska Air Group, Inc. (NYSE: ALK), the parent company of Alaska Airlines and Horizon Air, has been maintained with a Strong Buy rating by Raymond James, who raised the price target from $70 to $75. Despite $ALK closing at $49.25 on Friday, the re. Read more

June 26th, 2023

Shares of Pharvaris N.V. (Nasdaq: PHVS) surged over 10% in pre-market trading after the clinical-stage company announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on its Investigational New Drug (IND) application f. Read more